Cleared Traditional

K122810 - COMPACT DIGITAL BLOOD PRESSURE MONITOR

K122810 is the FDA 510(k) clearance for COMPACT DIGITAL BLOOD PRESSURE MONITOR by Thermor , Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 148-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2013
Decision
148d
Days
Class 2
Risk

K122810 is an FDA 510(k) clearance for the COMPACT DIGITAL BLOOD PRESSURE MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Thermor , Ltd. (Newmarket, CA). The FDA issued a Cleared decision on February 8, 2013 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Thermor , Ltd. devices

Submission Details

510(k) Number K122810 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2012
Decision Date February 08, 2013
Days to Decision 148 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
23d slower than avg
Panel avg: 125d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K122810.
NEXFIN MODEL 2
K122381 · Edwards Lifesciences, LLC · Apr 2013
APPS-HEALTH01
K122098 · Andon Health Co, Ltd. · Mar 2013
BP652N (HEM-6300-Z)
K123498 · Omron Healthcare, Inc. · Mar 2013
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K121372 · Andon Health Co, Ltd. · Sep 2012
HEM-7200-Z (BP742)
K121932 · Omron Healthcare, Inc. · Aug 2012
MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P
K120430 · Microlife Intellectual Property GmbH · Aug 2012